My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

5.520 -0.020 (-0.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 Next >
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into AVITA Medical, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
From AVITA Medical
Via GlobeNewswire
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
From AVITA Medical
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
RCEL Alert: Kirby McInerney LLP Encourages AVITA Medical, Inc. Investors to Inquire about Investigation
From Kirby McInerney LLP
Via Business Wire
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
From AVITA Medical
Via GlobeNewswire
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors
From Kirby McInerney LLP
Via GlobeNewswire
AVITA Medical Announces September Investor Conference Participation
From AVITA Medical
Via GlobeNewswire
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
AVITA Medical Successfully Completes Australian Equity Raise
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Appointment of Michael Tarnoff, MD, FACS, to its Board of Directors and Transition of Board Chair Role to Cary Vance
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Second Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™
From AVITA Medical
Via GlobeNewswire
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
From AVITA Medical
Via GlobeNewswire
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today
See how innovation is transforming patient outcomes through real-world clinical insights and patient stories 
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports First Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.